Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be age 5 or older
- You may qualify under one of several groups: (1) you have a genetic diagnosis of ALS4 (a specific gene mutation called SETX); (2) you have a genetic diagnosis of a related condition affecting how the body processes genetic material (such as RNaseH1, RNaseH2, or recessive SETX mutations); (3) you are a healthy family member (first, second, or third degree relative) of someone with one of these genetic mutations; (4) you are an unrelated healthy person with no such family history; or (5) you have a genetic diagnosis of a "gain of function" mutation (for example, certain mutations in SETX or KCC3)
- You must be able to communicate well with the research team and be willing and able to follow the study requirements
- Adults must be able to give their own consent to participate; children must be able to give their agreement (assent) to take part
Who may not be able to join:
- You are pregnant
- You have a known fear of enclosed spaces (claustrophobia), a pacemaker, metal in your body, or any other condition that would make having an MRI scan unsafe (applies to some groups — confirm with trial site)
- You have a diagnosed neuromuscular disease or show muscle weakness on a physical exam (applies to healthy control groups)
- For adults who would be asked to have a spinal fluid sample (lumbar puncture) taken: you have abnormal blood clotting test results, a low platelet count (below 70,000), a history of a bleeding disorder, or you are taking blood-thinning medications — these individuals would not be able to take part in that specific procedure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christopher Grunseich, M.D., National Institute of Neurological Disorders and Stroke (NINDS)
Phone: (301) 451-8146
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Disease progression as measured by thigh muscle volume and other study measures
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.